Thye Dirk has filed 13 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 1000000 shares of Quince Therapeutics, Inc. ($QNCX) on January 23, 2026.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 23, 2026 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO and CMO | A | Employee Stock Option (Right to Buy) | 1000000 | $0.00 | 1,000,000.0000 | 55,681,490 | 9999.99% | 1.80% |
| Dec. 10, 2025 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO and CMO | G | Common Shares | 739885 | $0.00 | 994,885.0000 | 55,681,490 | 290.15% | 1.33% |
| Dec. 10, 2025 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO and CMO | G | Common Shares | 739885 | $0.00 | 994,885.0000 | 55,681,490 | 42.65% | 1.33% |
| June 18, 2025 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO and CMO | A | Common Shares | 150944 | $1.20 | 994,885.0000 | 44,001,643 | 17.89% | 0.34% |
| June 18, 2025 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO and CMO | A | Warrants | 150944 | $0.13 | 150,944.0000 | 44,001,643 | 9999.99% | 0.34% |
| Jan. 28, 2025 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 1200000 | $0.00 | 1,200,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 30, 2024 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | P | Common Stock | 77000 | $0.70 | 843,941.0000 | 0 | 10.04% | 0.00% |
| Aug. 29, 2024 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | P | Common Stock | 77500 | $0.69 | 766,941.0000 | 0 | 11.24% | 0.00% |
| Feb. 1, 2024 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CEO AND CHIEF MEDICAL OFFICER | A | Employee Stock Option (right to buy) | 1500000 | $0.00 | 1,500,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 16, 2024 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CHIEF EXECUTIVE OFFICER | M | Employee Stock Option (right to buy) | 149999 | $0.00 | 450,001.0000 | 0 | 25.00% | 0.00% |
| Jan. 16, 2024 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CHIEF EXECUTIVE OFFICER | M | Employee Stock Option (right to buy) | 90531 | $0.00 | 115,860.0000 | 0 | 43.86% | 0.00% |
| Jan. 16, 2024 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CHIEF EXECUTIVE OFFICER | M | Common Stock | 149999 | $0.94 | 689,441.0000 | 0 | 27.81% | 0.00% |
| Jan. 16, 2024 | Quince Therapeutics, Inc. | $QNCX | Thye Dirk | CHIEF EXECUTIVE OFFICER | M | Common Stock | 90531 | $0.55 | 539,442.0000 | 0 | 20.17% | 0.00% |